{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:13Z","timestamp":1787109913789,"version":"build-2736575974"},"reference-count":242,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4613,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.anpedi.2013.10.006","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T22:45:33Z","timestamp":1389134733000},"page":"55.e1-55.e37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2014"],"prefix":"10.1016","volume":"80","author":[{"given":"D.","family":"Moreno-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ar\u00edstegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Corretger Rauet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Garc\u00eda S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hern\u00e1ndez Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hern\u00e1ndez-Sampelayo Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2013.10.006_bib0005","doi-asserted-by":"crossref","first-page":"43.e1","DOI":"10.1016\/j.anpedi.2011.10.008","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2012","volume":"76","author":"Moreno-P\u00e9rez","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0010","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.anpedi.2012.10.002","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2013","volume":"78","author":"Moreno-P\u00e9rez","year":"2013","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0015","unstructured":"Calendarios de vacunaci\u00f3n de las ciudades y comunidades aut\u00f3nomas espa\u00f1olas. Web de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda de Atenci\u00f3n Primaria [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aepap.org\/vacunas\/calendarios-espanoles"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0020","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Calendario com\u00fan de vacunaci\u00f3n infantil; 21 de marzo de 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/CalendarioVacunacionmar2013.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0025","unstructured":"Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). Recommended immunization schedules for persons aged 0 to 18 years and adults aged 19 years and older-United States, 2013. MMWR. 2013; 62(Suppl 1):1-19 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/mmwr\/pdf\/other\/su6201.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0030","unstructured":"Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP); Part 1: Immunization of infants, children, and adolescents. MMWR. 2005; 54(RR16):1-33 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5416a1.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0035","unstructured":"Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011; 60(RR02):1-60 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr6002.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.2013.276701","article-title":"Thirty-year outcomes of the national hepatitis B immunization program in Taiwan","volume":"310","author":"Chiang","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0045","unstructured":"Enfermedades de declaraci\u00f3n obligatoria. Series Temporales. A\u00f1o 2012. Instituto de Salud Carlos III [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/EDO2012.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0050","unstructured":"Situaci\u00f3n de la tosferina en Espa\u00f1a. Red Nacional de Vigilancia Epidemiol\u00f3gica de Espa\u00f1a. A\u00f1o 2009. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/Informetosferinajunio2009.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0055","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Coberturas de vacunaci\u00f3n. Datos estad\u00edsticos [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/coberturas.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0060","unstructured":"Grupo de trabajo tos ferina 2012. Ponencia de Programa y Registro de Vacunaciones. Revisi\u00f3n del programa de vacunaci\u00f3n frente a tos ferina en Espa\u00f1a. Enero 2013. Ministerio de Sanidad, Servicios Sociales e Igualdad [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/msc.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/TosFerina.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0065","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001478.pub5","article-title":"Acellular vaccines for preventing whooping cough in children","volume":"3","author":"Zhang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/hv.18650","volume":"8","author":"Ferrera","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0080","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.1542\/peds.2012-1928","article-title":"Waning immunity to pertussis following 5 doses of DTaP","volume":"131","author":"Tartof","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0085","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0090","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2012.14939","article-title":"Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010","volume":"308","author":"Misegades","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0095","doi-asserted-by":"crossref","first-page":"f4249","DOI":"10.1136\/bmj.f4249","article-title":"Effectiviness of pertussis vaccines for adolescents and adults: Case-control study","volume":"347","author":"Baxter","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0100","unstructured":"Boostrix\u00ae. Ficha t\u00e9cnica. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=63684&formato=pdf&formulario=FICHAS"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0105","unstructured":"Triaxis\u00ae. Ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=71870&formato=pdf&formulario=FICHAS"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0110","unstructured":"ECDC. Pertussis vaccination overview in European countries [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/pertussis.html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0115","unstructured":"NHS. The complete routine immunisation schedule 2013\/14 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/227651\/8515_DoH_Complete_Imm_schedule_A4_2013_09.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0120","unstructured":"Ponencia de Programa y Registro de vacunaciones 4 de febrero de 2010. Propuesta de recomendaci\u00f3n para la sustituci\u00f3n de la vacuna DTPa, como quinta dosis por una vacuna dTpa en el calendario de vacunaci\u00f3n infantil recomendado por el CISNS. Documento interno de 16 de febrero del 2010 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aragon.es\/estaticos\/GobiernoAragon\/Departamentos\/SaludConsumo\/Profesionales\/13_SaludPublica\/20_Programas_Salud\/Propuesta_recomendacion_sustitucion_vacuna_DTPa.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40259-012-0009-y","article-title":"Reduced\u2013antigen, combined diphteria, tetanus, and acellular pertussis vaccine, adsorbed (Boostrix\u00ae): a guide to its use as a single-dose booster immunization against pertussis","volume":"27","author":"Scott","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0130","unstructured":"Organizaci\u00f3n Mundial de la Salud. Calendarios del mundo [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0135","unstructured":"Ministerio de Sanidad y Consumo. Vacunaci\u00f3n en adultos. Recomendaciones vacuna de difteria y t\u00e9tanos. Actualizaci\u00f3n 2009. Documento aprobado por la Direcci\u00f3n General de Salud P\u00fablica; 18 de febrero del 2009 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/TetanosDifteria_2009.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eimc.2012.12.011","article-title":"Tos ferina en Espa\u00f1a. Situaci\u00f3n epidemiol\u00f3gica y estrategias de prevenci\u00f3n y control. Recomendaciones del Grupo de Trabajo de Tos ferina","volume":"31","author":"Campins","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0145","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.2011-2594","article-title":"Why do pertussis vaccines fail?","volume":"129","author":"Cherry","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.8.2.153","article-title":"Pertusis vaccination in newborns","volume":"8","author":"Ulloa Gutierrez","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOP.0b013e32834e8fe9","article-title":"Cocooning: A concept to protect young children from infectious diseases","volume":"24","author":"Grizas","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0160","doi-asserted-by":"crossref","first-page":"e1748","DOI":"10.1542\/peds.2012-3144","article-title":"Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: A decision analysis","volume":"131","author":"Terranella","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0165","unstructured":"The Joint Committee on Vaccination and Immunisation (JCVI). Temporary programme of pertussis (whooping cough) vaccination of pregnant women, September 27th 2012 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/www.wp.dh.gov.uk\/publications\/files\/2012\/09\/CMO-Pertussis-27-09-2012-FINAL.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0170","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women \u2014 Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CMR.00003-08","article-title":"Pertusis vaccination for health care workers","volume":"21","author":"Sandora","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0180","unstructured":"Ministerio de Sanidad y Consumo. Salud p\u00fablica: promoci\u00f3n de la salud y epidemiolog\u00eda. Vacunaci\u00f3n en adultos. Recomendaciones a\u00f1o 2004. Vacuna de tos ferina [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/recoVacunasAdultos.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rational pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0190","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older-Advisory Committee on Immunization Practices (ACIP), 2012","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0195","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4161\/hv.6.10.13017","article-title":"Haemophilus influenzae type b conjugate vaccines. Considerations for vaccination schedules and implications for developing countries","volume":"6","author":"Fitzwater","year":"2010","journal-title":"Human Vaccin"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0200","unstructured":"Centers for Disease Control and Prevention. Travelers\u2019 Health. Yellow Book 2014. Chapter 3. Infectious diseases related to travel. Poliomyelitis [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-3-infectious-diseases-related-to-travel\/poliomyelitis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0205","doi-asserted-by":"crossref","unstructured":"Bar-On ES, Goldber E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB) Cochrane Database of Systematic Reviews. 2012 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD005530.pub3\/full","DOI":"10.1002\/14651858.CD005530.pub3"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1542\/peds.2012-2617","article-title":"Vaccination site and risk of local reactions in children 1 through 6 years of age","volume":"131","author":"Jackson","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0215","first-page":"233","article-title":"Enfermedad meningoc\u00f3cica en Espa\u00f1a. An\u00e1lisis de la temporada 2009-2010","volume":"19","author":"Cano","year":"2011","journal-title":"Bol Epidemiol Sem"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0220","unstructured":"Red Nacional de Vigilancia Epidemiol\u00f3gica. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Enfermedad meningoc\u00f3cica en Espa\u00f1a. An\u00e1lisis de la temporada 2011-2012 y 2012-2013. Bol Epidemiol Sem. 2012 y 2013"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0225","unstructured":"Grupo de Trabajo de Enfermedad Meningoc\u00f3cica de la Ponencia de Programa y Registro de Vacunaci\u00f3n. Situaci\u00f3n actual de la enfermedad meningoc\u00f3cica en Espa\u00f1a. Modificaci\u00f3n de la pauta de vacunaci\u00f3n frente a meningitis C [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/msc.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/MenC_MARZO_2006.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0230","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2013.10.006_bib0235","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: The experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0240","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0245","unstructured":"I encuesta de seroprevalencia de la Comunidad Aut\u00f3noma del Pa\u00eds Vasco. Vitoria:Servicio de Publicaciones del Gobierno Vasco;2011."},{"key":"10.1016\/j.anpedi.2013.10.006_bib0250","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/CVI.00279-08","article-title":"Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era","volume":"15","author":"Trotter Cl","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0260","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/CVI.05655-11","article-title":"Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction","volume":"19","author":"Ishola","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0265","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C menningococcal disease in adolescents in the United Kingdom: Observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0270","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary school children in 1999-2000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months","volume":"29","author":"D\u00edez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0285","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/INF.0b013e31824f34e6","article-title":"Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in United Kingdom","volume":"31","author":"Findlow","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0290","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and heard immunity: Lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0295","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: A systematic review and metaanalysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0300","unstructured":"JCVI statement on the use of meningococcal C vaccines in the routine childhood immunisation programme, 29 January 2012 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_132443.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0305","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1542\/peds.2011-2380","article-title":"Meningococcal conjugate vaccines policy update: Booster dose recommendations","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0310","first-page":"52","article-title":"Infant meningococcal vaccination: Advisory Committee on Immunization practices (ACIP) recommendations and rationale","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0315","unstructured":"Revisi\u00f3n del programa de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica por serogrupo C. Grupo de trabajo MenCC 2012. Ponencia de Programa y Registro de Vacunaciones. Enero de 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenC.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CVI.00516-10","article-title":"Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age","volume":"18","author":"Miller","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0325","unstructured":"Fichas t\u00e9cnicas de Meningitec\u00ae, Menjugate\u00ae, NeisVac C\u00ae, Menveo\u00ae y Nimenrix\u00ae. Agencia Espa\u00f1ola de Medicamentos y Productos sanitarios. Ministerio de Sanidad, Servicios Sociales e Igualdad [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=150"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0330","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1517\/14712598.2013.812629","article-title":"Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): A review","volume":"13","author":"Ghanem","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12325-013-0032-5","article-title":"Immunogenicity and safety of meningococcal serogroup A, C, Y and W glycoconjugate vaccine ACWY-TT","volume":"30","author":"Findlow","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0340","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2013WHO position paper","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0345","first-page":"308","article-title":"Progress in introduction of pneumococcal conjugate vaccine \u2013 Worldwide, 2000-2011","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0350","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/CVI.00239-13","article-title":"Expanding serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age -and serotype- dependent incidence of invasive pneumococcal clinical presentations (Madrid, Spain)","volume":"20","author":"Picazo","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0360","unstructured":"HPA 2013. Pneumococcal disease. Epidemiological data. Current epidemiology of Invasive Pneumococcal Disease (IPD). En: Prevenar 13 (not In Prevenar PCV7) [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/Pneumococcal\/EpidemiologicalDataPneumococcal\/CurrentEpidemiologyPneumococcal\/InPrevenar13NotInPrevenarPCV7\/"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0365","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia alter a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0370","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: A time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0375","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0380","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/INF.0b013e31817cf76f","article-title":"Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"27","author":"De Wals","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0385","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011","volume":"19","author":"Ritcher","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/003335490512000209","article-title":"A Population-based analysis of pneumococcal disease mortality en California, 1989-1998","volume":"120","author":"Redelings","year":"2005","journal-title":"Public Health Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0400","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.vaccine.2008.05.033","article-title":"Serotypes and pathogens in paediatric pneumonia","volume":"265","author":"Hausdorff","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0405","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0410","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valen pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: A randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0415.1","unstructured":"Desai AP, Sharma D, Crispell E, Baughman W, Thomas S, Holst A, et al. Pneumococcal (SP) nasopharyngeal carriage in children in Atlanta, Georgia in the post-PCV13 era. En: IDweek, San Diego, CA, 17-21 October 2012"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0415.2","unstructured":"p\u00f3ster 509 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/idsa.confex.com\/idsa\/2012\/webprogram\/Paper36589.html"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0420.1","unstructured":"Pelton SI, Loughlin A, Marchant C, Hsu K. Indirect effects of PCV13 on nasopharyngeal colonization with Streptococcus pneumoniae (SP) vaccine serotypes achieved with 65%-75% vaccine uptake. En: IDweek, San Diego, CA, 17-21 October 2012"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0420.2","unstructured":"p\u00f3ster LB-6 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/idsa.confex.com\/idsa\/2012\/webprogram\/Paper38528.html"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0425.1","unstructured":"Moore M, Link-Gelles R, Farley MM, Schaffner W, Thomas A, Reingold A, et al. Impact of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease, U.S., 2010-11. In: IDWeek, San Diego, CA, 17-21 October 2012"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib0425.2","unstructured":"p\u00f3ster 1219 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/idsa.confex.com\/idsa\/2012\/webprogram\/Paper36569.html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0430","doi-asserted-by":"crossref","unstructured":"Dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CRM, Gilio AE, et al. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after-ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.05.042. En prensa","DOI":"10.1016\/j.vaccine.2013.05.042"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0435","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0440","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1016\/j.vaccine.2012.08.017","article-title":"Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and\/or PHiD-CV in the province of Quebec, Canada","volume":"30","author":"De Wals","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0445","unstructured":"Mrkvan T, Hoet B, Adegbola RA, van Dyke M, Hausdorff WP. Serotype 19A and the 10- valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHID-CV): Lessons learned to date. En: Abstract presented at 31st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 2013 May 28-June 1; Milan, Italy. Abstract 376."},{"key":"10.1016\/j.anpedi.2013.10.006_bib0450","unstructured":"Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen M, Nohynek H, et al. Indirect impact of 10-valent pneumococcal conjugate vaccine (PCV10) against invasive pneumococcal disease (IPD) among unvaccinated children in Finland. En: Abstract presented at 31st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 2013 May 28-June 1; Milan, Italy. Abstract 225."},{"key":"10.1016\/j.anpedi.2013.10.006_bib0455","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae proteinD\u2013conjugate vaccine on nasopharyngeal bacterial colonization in young children: A randomized controlled trial","volume":"56","author":"Van den Bergh","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0460","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0465","unstructured":"European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report 2012. 5 marzo 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/ecdc.europa.eu\/es\/publications\/Publications\/Annual-Epidemiological-Report-2012.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0470","doi-asserted-by":"crossref","unstructured":"Greaves F, Donaldson L. Measles in the UK: A test of public health competency in a crisis. BMJ. 2013; 346:f 2793 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.bmj.com\/content\/346\/bmj.f2793","DOI":"10.1136\/bmj.f2793"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0475","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance report. Measles and rubella monitoring. June 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Measles-rubella-monitoring_June_2013.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0480","unstructured":"Health Protection Report 7 (36): News [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.hpa.org.uk\/hpr\/archives\/2013\/news3613.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0485","unstructured":"RIVM (Instituto Nacional de Salud P\u00fablica de Holanda) [\u00faltimo acceso 30 Sept 2013]. Disponible en http:\/\/www.rivm.nl\/en\/Topics\/M\/Measles"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0490","first-page":"741","article-title":"Measles-United States, January 1-August 24, 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0495","unstructured":"Generalitat de Catalunya. L\u2019eliminaci\u00f3 del xarampi\u00f3 a Catalunya per a l\u2019any 2000. Bases cient\u00edfiques i programa [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www20.gencat.cat\/docs\/canalsalut\/Home%20Canal%20Salut\/Professionals\/Temes_de_salut\/Vigilancia_epidemiologica\/documents\/eliminacio_xarampio.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0500","doi-asserted-by":"crossref","first-page":"20426","DOI":"10.2807\/ese.18.11.20426-en","article-title":"Outbreaks associated to large open air festivals, including music festivals, 1980 to 2012","volume":"18","author":"Botelho-Nevers","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0505","doi-asserted-by":"crossref","first-page":"c1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0510","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2012.07.035","article-title":"Measles outbreak in Europe: Susceptibility of infants too young to be immunized","volume":"30","author":"Leuridan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0515","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00431-012-1691-y","article-title":"Maternal mumps antibodies in a cohort of children up to the age of 1 year","volume":"171","author":"Leuridan","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0520","unstructured":"Informe epidemiol\u00f3gico de la parotiditis en la Comunidad del Principado de Asturias. Oviedo, 29 de enero de 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.asturias.es\/portal\/site\/astursalud\/menuitem.2d7ff2df00b62567dbdfb51020688a0c\/?vgnextoid=ce9a197f9259c310VgnVCM10000097030a0aRCRD&vgnextchannel=14dba524c1f33310VgnVCM10000097030a0aRCRD"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0525","unstructured":"Informe epidemiol\u00f3gico de la parotiditis en la Comunidad de Madrid. Servicio Madrile\u00f1o de Salud. Madrid, 9 de julio de 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.madrid.org\/cs\/Satellite?cid=1142350639343&language=es&pagename=PortalSalud%2FPage%2FPTSA_pintarContenidoFinal"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0530","unstructured":"ECDC. EUVAC net. Calendarios europeos [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/euvac\/schedules\/Pages\/schedules.aspx"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0535","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Eliminaci\u00f3n del sarampi\u00f3n. Gu\u00eda pr\u00e1ctica. 2.a ed. Publicaci\u00f3n cient\u00edfica y t\u00e9cnica, n.\u00b0 605. Washington: OMS; 2007."},{"key":"10.1016\/j.anpedi.2013.10.006_bib0540","unstructured":"Centers for Disease Control and Prevention (CDC). Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013; 62(RR04);1-34 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6204a1.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0545","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1542\/peds.2012-0177","article-title":"Impact of third dose of measles-mumps-rubella vaccine on a mumps outbreak","volume":"130","author":"Ogbuanu","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0550","unstructured":"Mumps. Epidemiology and Prevention of Vaccine-Preventable Diseases. The pink book: Course textbook - 12th Edition, Second Printing (May 2012) [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/mumps.html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0555","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3201\/eid1909.130299","article-title":"Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, orange county, New York, USA","volume":"19","author":"Fiebelkorn","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0560","unstructured":"Ficha t\u00e9cnica de Gardasil\u00ae [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000703\/WC500021142.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0565","unstructured":"Ficha t\u00e9cnica de Cervarix\u00ae [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000721\/WC500024632.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0570","unstructured":"Ficha t\u00e9cnica Gardasil\u00ae (FDA) [\u00faltima actualizaci\u00f3n 22 Dic 2010; \u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm237941.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0575","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0580","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0585","series-title":"XX FIGO World Congress of Gynecology and Obstetrics Roma","article-title":"Immune response to the HPV-16\/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 3 years after vaccination","author":"Schwarz","year":"2012"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0590","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: A systematic review and metaanalysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0600","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0605","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0610","first-page":"325","article-title":"Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0615","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0620","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jmv.23282","article-title":"Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study","volume":"84","author":"Castellsagu\u00e9","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0625","unstructured":"Documento de consenso 2011 de Sociedades Cient\u00edficas Espa\u00f1olas. Vacunaci\u00f3n frente al virus del papiloma humano [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/sites\/vacunasaep.org\/files\/VPH_Consenso_Sociedades_2011.pdf"},{"issue":"2 Suppl","key":"10.1016\/j.anpedi.2013.10.006_bib0630","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2010.01.026","article-title":"Epidemiology and pathology of HPV disease in males","volume":"117","author":"Giuliano","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0635","doi-asserted-by":"crossref","first-page":"e54375","DOI":"10.1371\/journal.pone.0054375","article-title":"Human papillomavirus infection in a male population attending a sexually transmitted infection service","volume":"8","author":"\u00c1lvarez-Arg\u00fcelles","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0640","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0645","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-12-30","article-title":"Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: A review","volume":"12","author":"Hartwig","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0650","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0655","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0660","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jadohealth.2008.10.002","article-title":"Immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years","volume":"44","author":"Pet\u00e4j\u00e4","year":"2009","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0665","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males-ACIP, 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0670","first-page":"602","article-title":"Committee on Infectious Diseases","volume":"129","year":"2012","journal-title":"HPV vaccine recommendations Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0675","unstructured":"Department of Health and Ageing. Australian Government. National immunisation program-human papillomavirus vaccination for boys [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/immunise-hpv"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0680","unstructured":"National Advisory Committee on Immunization (NACI). Public Health Agency of Canada. Update on human papillomavirus (HPV) vaccines. CCDR. 2012;38. ACS1 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/12vol38\/acs-dcc-1\/index-eng.php"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0685","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0690","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/11599470-000000000-00000","article-title":"The cost effectiveness of human papillomavirus vaccines: a systematic review","volume":"72","author":"Seto","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0695","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2334-12-62","article-title":"Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: A scoping review","volume":"12","author":"Ogilvie","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0700","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-13-112","article-title":"The impact of rotavirus mass vaccination on hospitalization rates, nosocomial rotavirus gastroenteritis and secondary blood stream infections","volume":"13","author":"Zlamy","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0705","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2011.01.104","article-title":"Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria","volume":"29","author":"Paulke-Korinek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0710","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/INF.0b013e31828d639c","article-title":"Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012","volume":"32","author":"Tate","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0715","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/mja12.10062","article-title":"Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program","volume":"197","author":"Dey","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0720","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cis1010","article-title":"Indirect protection of adults from rotavirus by pediatric rotavirus vaccination","volume":"56","author":"Anderson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0725","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2013.02.007","article-title":"Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: The Australian experience","volume":"31","author":"Hull","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0730","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2013.170800","article-title":"Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination","volume":"310","author":"Gasta\u00f1aduy","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0735","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.meegid.2013.06.026","article-title":"Genetic diversity of G1P[8] rotavirus VP7 and VP8 antigens in Finland over a 20-year period: No evidence for election pressure by universal mass vaccination with RotaTeq\u00ae vaccine","volume":"19","author":"Hemming","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0740","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MPG.0b013e31828dc35d","article-title":"Rotavirus vaccination in central Europe","volume":"56","author":"M\u00e9szner","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0745","unstructured":"European Centre for Disease Prevention and Control. Impact of rotavirus vaccination. Generic study protocol. Stockholm: ECDC; 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/ecdc.europa.eu\/en\/publications\/publications\/rotavirus-impact-vaccination-april-2013.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0750","unstructured":"European Centre for Disease Prevention and Control. Effectiveness of rotavirus vaccination-Generic study protocol for retrospective case control studies based on computerised databases. Stockholm: ECDC; 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/ecdc.europa.eu\/en\/publications\/publications\/rotavirus-vaccination-case-control-april2013.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0755","unstructured":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios. Nota informativa: liberaci\u00f3n de lotes de la vacuna RotaTeq\u00ae. AEMPS, 4 de noviembre de 2010 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/calidad\/2010\/NI-circovirus-rotateq_noviembre-2010.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0760","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4161\/hv.24182","article-title":"A reverse evidence of rotavirus vaccines impact","volume":"9","author":"Martin\u00f3n-Torres","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0765","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2012-3804","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccine","volume":"132","author":"Cortese","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0770","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1016\/j.vaccine.2013.06.085","article-title":"Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact","volume":"31","author":"Kilgore","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0775","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0780","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0785","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012","volume":"131","author":"Haber","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0790","unstructured":"World Health Organization (WHO). Rotavirus vaccine and intussusception: Report from an expert consultation. Wkly Epidem Rec. 2011; 86:317-324 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.who.int\/wer\/2011\/wer8630.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0795","unstructured":"World Health Organization (WHO). Rotavirus vaccines. WHO position paper\u2013January 2013. Wkly Epidemiol Rec. 2013;88:49-64 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.who.int\/wer\/2013\/wer8805.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0800","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/INF.0b013e3182490a2c","article-title":"Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase iiib study","volume":"31","author":"Ome\u00f1aca","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0805","series-title":"Vacunas en Pediatr\u00eda. Manual de la AEP 2012. Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Comit\u00e9 Asesor de Vacunas","first-page":"67","article-title":"El acto de la vacunaci\u00f3n. Antes, durante y despu\u00e9s de vacunar","author":"Hern\u00e1ndez","year":"2012"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0810","unstructured":"Varicela. Epidemiolog\u00eda y situaci\u00f3n actual. Vacunas: caracter\u00edsticas y eficacia\/efectividad. Recomendaciones de vacunaci\u00f3n y sus implicaciones en Salud P\u00fablica. Mayo 2005 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.msssi.gob.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/VARICELA1.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0815","unstructured":"Resoluci\u00f3n de 24 de julio de 2013 de la Direcci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n, por la que se publica el Acuerdo del Consejo Interterritorial del Sistema Nacional de Salud sobre el calendario com\u00fan de vacunaci\u00f3n infantil. BOE n\u00fam. 187, martes 6 de agosto de 2013, p\u00e1gs. 57629-31 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.boe.es\/boe\/dias\/2013\/08\/06\/pdfs\/BOE-A-2013-8700.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0820","unstructured":"Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007; 56(RR04);1-40 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5604a1.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0825","unstructured":"Centers for Disease Control and Prevention (CDC). Monitoring the impact of varicella vaccination. [Internet] [actualizado el 30 Ago 2012] [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/chickenpox\/hcp\/monitoring-varicella.html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0830","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2807\/ese.15.13.19530-en","article-title":"Impact of the routine varicella vaccination programme on varicella epidemiology in Germany","volume":"15","author":"Siedler","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0835","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/INF.0b013e318260cc4d","article-title":"The effect of funded varicella immunization programs on varicella related hospitalizations in IMPACT centers, Canada, 2000-2008","volume":"31","author":"Tan","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0840","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1016\/j.vaccine.2011.10.022","article-title":"Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy","volume":"29","author":"Pozza","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0845","unstructured":"Servicio Madrile\u00f1o de Salud, Direcci\u00f3n General de Atenci\u00f3n Primaria. Servicio de Epidemiolog\u00eda. Morbilidad por enfermedades de declaraci\u00f3n obligatoria, a\u00f1o 2011 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/goo.gl\/UJDsv"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0850","unstructured":"Servicio Madrile\u00f1o de Salud, Direcci\u00f3n General de Atenci\u00f3n Primaria. Servicio de Epidemiolog\u00eda. Red de M\u00e9dicos Centinela en la Comunidad de Madrid, a\u00f1o 2011 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/goo.gl\/UlYXX"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0855","unstructured":"Comit\u00e9 Asesor de Vacunas de la Comunidad de Madrid. Informe sobre varicela en la Comunidad de Madrid, 2010 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/goo.gl\/Md2ya"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0860","unstructured":"Situaci\u00f3n de las enfermedades de declaraci\u00f3n obligatoria en Navarra, 2012. Bol Inform ISP. 2013;(71):1-3 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.navarra.es\/NR\/rdonlyres\/AECCD760-AB2A-4841-818A-FA53478FD6DC\/247355\/BOL71INTedos2012.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0865","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.32.20552","article-title":"Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012","volume":"18","author":"Garc\u00eda Cenoz","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0870","unstructured":"Euvac.Net. Varicella vaccination overview in European countries [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/var.html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0875","doi-asserted-by":"crossref","unstructured":"Field N, Amirthalingama G, Waight P, Andrews N, Ladhani SN, van Hoek AJ, et al. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England. Vaccine. 2013 Jul 16 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.06.098","DOI":"10.1016\/j.vaccine.2013.06.098"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0880","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella vaccine over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0885","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1016\/j.vaccine.2012.05.072","article-title":"A varicela outbreak in a school with high one-dose vaccination coverage, Beijing, China","volume":"30","author":"Lu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0890","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.vaccine.2013.06.075","article-title":"Single-dose varicella vaccine effectiveness in school settings in China","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0895","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: A 14-year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0900","unstructured":"Goldman GS. A significant confounder in the long-term effectiveness of varicella vaccine: A 14-year, prospective cohort study. Pediatrics. 2013; 131:1-8 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/pediatrics.aappublications.org\/content\/early\/2013\/03\/27\/peds.2012-3303.full.pdf+html"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0905","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain","volume":"9","author":"Garcia Cenoz","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0910","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicela vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0915","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0920","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.4161\/hv.25228","article-title":"Economic evaluation of varicella vaccination: Results of a systematic review","volume":"9","author":"Unim","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0925","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicela vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0930","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: Implications for interval between 2 doses","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0935","unstructured":"Fichas t\u00e9cnicas de Varilrix\u00ae y Varivax\u00ae [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=157"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0940","first-page":"413","article-title":"Documento de consenso para la vacunaci\u00f3n en inmunodeprimidos","volume":"75","author":"Mellado Pe\u00f1a","year":"2011","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0945","unstructured":"Servicio de Epidemiolog\u00eda, Comunidad de Madrid. Estudio de vigilancia poblacional para estimar la carga del herpes z\u00f3ster y la neuralgia postherp\u00e9tica en Espa\u00f1a. Informe de situaci\u00f3n n.\u00b0 5 (13 de septiembre de 2013)."},{"key":"10.1016\/j.anpedi.2013.10.006_bib0950","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4321\/S1139-76322009000400003","article-title":"Cobertura de vacuna antigripal en ni\u00f1os de riesgo durante 2007-2008 en un centro de Atenci\u00f3n Primaria en Espa\u00f1a","volume":"11","author":"Dom\u00ednguez Cajal","year":"2009","journal-title":"Rev Pediatr Aten Primaria"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0955","unstructured":"Consenso sobre la vacunaci\u00f3n frente a la gripe en el personal sanitario [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/documentos\/documento-de-consenso-sobre-vacunacion-del-personal-sanitario-contra-la-gripe"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0960","unstructured":"Vacunaci\u00f3n frente a la gripe estacional en la infancia y la adolescencia. Recomendaciones del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (CAV-AEP) para la campa\u00f1a 2013-2014 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/documentos\/recomendaciones-vacunacion-gripe-2013-14"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0965","unstructured":"World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/201302_recommendation.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0970","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1016\/j.vaccine.2011.08.010","article-title":"Seasonal influenza: The burden of disease in children","volume":"29","author":"Fraaij","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0975","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-8-349","article-title":"Viral shedding in children infected by pandemic A\/H1N1\/2009 influenza virus","volume":"8","author":"Esposito","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0980","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e3181fe37c8","article-title":"Incidence of influenza-related hospitalizations in different age groups of children in Finland: A 16-year study","volume":"30","author":"Silvennoinen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0985","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0990","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.anpedi.2013.03.005","article-title":"Vacunaci\u00f3n antigripal universal en pediatr\u00eda: \u00bfs\u00ed o no?","volume":"79","author":"Gonz\u00e1lez de Dios","year":"2013","journal-title":"An Pediatr"},{"key":"10.1016\/j.anpedi.2013.10.006_bib0995","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","volume":"2","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1000","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: A meta-analysis on nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1005","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1016\/j.vaccine.2011.08.008","article-title":"A systematic review of the evidence of the effectiveness and risk of inactivated influenza vaccines in different target groups","volume":"29","author":"Michiels","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1010","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.vaccine.2011.08.011","article-title":"Effectiveness and safety of influenza vaccination in children: European perspective","volume":"29","author":"Heikkinen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib1020.1","unstructured":"Centers for Disease Control and Prevention (CDC). Summary recommendations: Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2013-14. MMWR. 2013"},{"key":"#cr-split#-10.1016\/j.anpedi.2013.10.006_bib1020.2","unstructured":"62(RR07):1-43 [\u00faltimo acceso 30 Sept 2013]. en: http:\/\/www.cdc.gov\/flu\/professionals\/acip\/2013-summary-recommendations.htm"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1025","unstructured":"Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Fichas t\u00e9cnicas de vacunas antigripales [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/fichas-tecnicas-vacunas\/resultados?diseases=148"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1030","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2013-304681","article-title":"Should all children be immunised against influenza?","author":"Thors","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/INF.0b013e3182918168","article-title":"Vaccination of healthy children against seasonal influenza. A European perspective","volume":"32","author":"Heikkinen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1040","first-page":"93","article-title":"Encuesta nacional de seroprevalencia de enfermedades inmunoprevenibles. A\u00f1o 1996","volume":"6","author":"Pach\u00f3n","year":"1998","journal-title":"Bol Epidemiol Sanit"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1045","unstructured":"Vacuna hepatitis A (grupos de riesgo). Circular 15\/1998 de la Direcci\u00f3n General de Farmacia y Productos Sanitarios."},{"key":"10.1016\/j.anpedi.2013.10.006_bib1050","first-page":"346","article-title":"Recomendaciones para el uso de la vacuna de la hepatitis A en guarder\u00edas","volume":"21","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2007-1088","article-title":"Hepatitis A vaccine recommendations","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1060","first-page":"261","article-title":"WHO position paper on hepatitis A vaccines-June 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1065","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/jmv.22200","article-title":"Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: Long-term follow-up at 15 years","volume":"83","author":"Van Herck","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2012.04.104","article-title":"Long-term protective effects of hepatitis A vaccines. A systematic review","volume":"31","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4161\/hv.18617","article-title":"Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine","volume":"8","author":"Van Herck","year":"2012","journal-title":"Human Vaccines Immunotherap"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1080","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.vaccine.2013.02.048","article-title":"Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children","volume":"31","author":"Raczniaka","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2013.04.012","article-title":"Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations","author":"Ott","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1576-9887(12)70057-2","article-title":"Programas de vacunaci\u00f3n universal contra la hepatitis A en el mundo","volume":"13","author":"Aldea Novoa","year":"2012","journal-title":"Vacunas"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1095","first-page":"15","article-title":"Hepatitis A. Una reflexi\u00f3n, desde la ciudad aut\u00f3noma de Melilla, tras la introducci\u00f3n de la vacuna","volume":"1","author":"Castrillejo","year":"2011","journal-title":"Newsletter Hepatitis A: Epidemiolog\u00eda"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1100","first-page":"12","article-title":"Incidencia de la hepatitis A en Ceuta","volume":"1","author":"P\u00e9rez","year":"2011","journal-title":"Newsletter Hepatitis A: Epidemiolog\u00eda"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1105","unstructured":"Bolet\u00edn epidemiol\u00f3gico de la Ciudad Aut\u00f3noma de Ceuta. Ceuta: Servicio de Vigilancia Epidemiol\u00f3gica, Consejer\u00eda de Sanidad y Consumo; 2012 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.ceuta.es\/ceuta\/documentos\/finish\/1442-2012\/7463-boletin-18-junio"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(02)00583-2","article-title":"Effectiveness of a mass hepatitis A vaccination program in preadolescents","volume":"21","author":"Dom\u00ednguez","year":"2003","journal-title":"Vaccine"},{"issue":"suppl. 2","key":"10.1016\/j.anpedi.2013.10.006_bib1115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2893.2008.01030.x","article-title":"Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain","volume":"15","author":"Dom\u00ednguez","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1120","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.vaccine.2008.01.048","article-title":"Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction","volume":"26","author":"Dom\u00ednguez","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1576-9887(09)71384-6","article-title":"Vacunaci\u00f3n antihepatitis A: \u00bf selectiva o universal?","volume":"10","author":"Rodr\u00edguez","year":"2009","journal-title":"Vacunas"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1130","unstructured":"European Medicines Agency. 15 November 2012. EMA\/CHMP\/669278\/2012. Committee for Medicinal Products for Human Use (CHMP)"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules. A randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1145","unstructured":"Ficha t\u00e9cnica Bexsero\u00ae [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/002333\/WC500137881.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CmenB) in Europe: A qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1155","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Informe de utilidad terap\u00e9utica. Vacuna meningoc\u00f3cica del grupo B, Bexsero; 5 de abril de 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/vacunas\/infoUtilTerapeutica\/docs\/infUtilTerap_Bexsero.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1160","unstructured":"Grupo de Trabajo MenB. Vacuna frente a enfermedad meningoc\u00f3cica invasora por serogrupo B y su posible utilizaci\u00f3n en salud p\u00fablica. Ponencia de Programas y registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/msc.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenB.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1165","unstructured":"JCVI interim position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK. July 2013 [\u00faltimo acceso 30 Sept 2013]. Disponible en: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224896\/JCVI_interim_statement_on_meningococcal_B_vaccination_for_web.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1170","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.vaccine.2013.03.034","article-title":"Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact","volume":"31","author":"Christensen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1180","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/INF.0b013e31827b0d24","article-title":"A randomized, controlled, phase 1\/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents","volume":"32","author":"Nissen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1185","unstructured":"Centers for Disease Control and Prevention (CDC). Catch-up immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/catchup-schedule-pr.pdf"},{"key":"10.1016\/j.anpedi.2013.10.006_bib1190","unstructured":"The Australian Immunisation Handbook, 10th Edition, 2013. Part 2 Vaccination procedures. 2.1 Pre-vaccination. 2.1.5 Catch-up [\u00faltimo acceso 30 Sept 2013]. Disponible en: http:\/\/www.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/handbook10-2-1"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313004104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403313004104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:36:42Z","timestamp":1787107002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403313004104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":242,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1695403313004104"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.10.006","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2014","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}